Binding studies of L-Prolyl-L-leucyl-glycinamide (PLG), a novel antiparkinsonian agent, in normal human brain
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 15 (1) , 41-51
- https://doi.org/10.1016/s0031-6989(83)80079-4
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Neuroleptic Drug-Induced Dopamine Receptor Supersensitivity: Antagonism by L-Prolyl-L-Leucyl-GlycinamideScience, 1981
- Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindingsPeptides, 1981
- Neuroendocrinology and brain peptidesAnnals of Neurology, 1980
- The striatum and substantia nigra: A commentary on their relationshipsNeuroscience, 1979
- MIF-I and postsynaptic receptor sites for dopamineBrain Research Bulletin, 1979
- Binding of opiates and endogenous opioid peptides to neuroleptic receptor sites in the corpus striatumLife Sciences, 1978
- Six Years of High-Level Levodopa Therapy in Severely Akinetic Parkinsonian PatientsArchives of Neurology, 1976
- POTENTIATION OF LEVODOPA EFFECT BY INTRAVENOUS L-PROLYL-L-LEUCYL-GLYCINE AMIDE IN MANThe Lancet, 1975
- Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in micePharmacology Biochemistry and Behavior, 1974
- Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlationsJournal of the Neurological Sciences, 1973